CDC Drops Universal Hepatitis B Vaccine Recommendation for Newborns

Historic Policy Reversal Sparks Medical Controversy

The Centers for Disease Control and Prevention officially approved a sweeping change to America's childhood immunization schedule Tuesday, abandoning its decades-long recommendation that all newborns receive a hepatitis B vaccine within 24 hours of birth. The controversial decision marks the first major policy shift by the newly reconstituted Advisory Committee on Immunization Practices, whose members were handpicked by Health Secretary Robert F. Kennedy Jr.

Under the new guidance, mothers who test negative for hepatitis B can now delay their infant's vaccination until at least two months of age after consulting with doctors, while mothers testing positive would continue to have their infants vaccinated within 24 hours of birth. Acting CDC Director Jim O'Neill defended the change, stating it "reflects ACIP's rigorous review of the available evidence" and "restores the balance of informed consent to parents whose newborns face little risk of contracting hepatitis B."

Medical Community Raises Alarm

The universal hepatitis B vaccination policy, in place since 1991, helped slash infections in children from an estimated 18,000 cases per year to about 20. Research shows hepatitis B infections among infants and children have dropped 99% over that time period. Medical experts warn the policy reversal could reverse these gains.

Dr. Susan Kressly, president of the American Academy of Pediatrics, said the panel's change makes children in America less safe, noting "they are vulnerable when we have a duty to most protect them" and that the committee "presented no information and no data that said this new approach is safer." Senator Bill Cassidy, a liver doctor who has treated hepatitis B patients, warned that "ending the recommendation for newborns makes it more likely the number of cases will begin to increase again."

Understanding the Stakes

Hepatitis B attacks the liver, and infected infants have a 90% chance of developing the disease's more dangerous chronic form, with a quarter of those babies going on to die prematurely from the disease when they become adults. Untreated chronic hepatitis B infections can cause cirrhosis and death, and the virus is one of the leading causes of liver cancer, with no cure available.

The virus is highly infectious and can survive on surfaces for up to a week, with small amounts of dried blood on household items like nail clippers or toothbrushes potentially causing infection. Even if a pregnant mother tests negative, her newborn can come in contact with the virus through other people and circumstances. About 16% of expecting mothers fall through testing cracks, making the birth dose "a critical safety net in the U.S. healthcare system" to protect against screening gaps and communication errors.

Political Implications and Future Impact

President Trump praised the panel's decision on social media, calling it "a very good decision to END their Hepatitis B Vaccine Recommendation for babies, the vast majority of whom are at NO RISK." Trump also signed a presidential memorandum directing HHS to evaluate vaccine schedules from other countries, claiming "peer, developed countries recommend fewer childhood vaccinations."

The change carries significant practical implications beyond medical recommendations, as ACIP's guidance influences insurance coverage requirements, with most private insurers required to cover recommended vaccines. Public health experts warn the new recommendation could expose more children to the harmful virus and lead to more families opting out of vaccination altogether in the absence of firm federal policy. As states decide whether to follow federal guidance or maintain their own standards, parents and healthcare providers now face navigating a more complex landscape of childhood immunization decisions.